Search
Search results
467 results found
Download
CellProfiler Analyst Stable (3.0.5): macOS Windows Source code available on Github Previous CellProfiler Analyst releases
Merkin Prize Jury
The Merkin Prize Jury is composed of scientific leaders from academia and industry in the US and Europe.
Nominate
Nominations for the 2026 Merkin Prize are now open. Click the ”nominate” button below to submit a nomination. Deadline: Friday, December 5, 2025 at 11:59 p.m. ET. Nominate Nomination Package Requirements Contact information for nominator Nominees’ names and organizations If available, please share...
Published pipelines
CellProfiler enables reproducible research because a saved pipeline includes all the modules and settings. Here, we provide links to pipelines used in some published studies, as well as the version of CellProfiler used to create them. You can instead download the most current version of CellProfiler...
2025 Merkin Prize in Biomedical Technology Recipients
Carl June University of Pennsylvania Perelman School of Medicine Carl June is the Richard W. Vague professor in immunotherapy at the Perelman School of Medicine at the University of Pennsylvania, where he is also the director of the Center for Cellular Immunotherapies. In addition, he is the...
News & Events
October 31, 2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy Produced by the Heritage Provider Network video team This groundbreaking form of personalized cancer immunotherapy...
2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy
FOR IMMEDIATE RELEASE CONTACT Karen Zusi-Tran Broad Institute kzusi@broadinstitute.org Janet Janjigian Heritage Provider Network janjigianj@carmengroup.com 424-354-0133 The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’...
Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy
This groundbreaking form of personalized cancer immunotherapy has had remarkable success — more than 45,000 cancer patients worldwide have been treated with CAR T-cell therapy, extending their lives and, in many cases, delivering complete and sustained remissions.
Our Team
The Sheng lab is committed to diversity, equity and inclusion and our lab is dedicated to ensuring a welcoming and safe space for all individuals. We actively work to increase the breadth of our applicant pools to create an environment that supports and retains a richly diverse community...